Animal Models of Respiratory Syncytial Virus Pathogenesis and Vaccine Development: Opportunities and Future Directions

QR Code

Animal Models of Respiratory Syncytial Virus Pathogenesis and Vaccine Development: Opportunities and Future Directions

None

Saved in:

Bibliographic Details
Main Authors:	Woolums, Amelia R., Lee, Sujin, Moore, Martin L.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24392
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy
by: Seby R, et al.
Published: (2025-07-01)

Respiratory Syncytial Virus Infection. Pathogenesis Peculiarities, Prevention and Treatment Strategies
by: V. Z. Krivitskaya
Published: (2013-03-01)

Current status of developments in the field of respiratory syncytial virus vaccines
by: Tatiana S. Kotomina
Published: (2025-05-01)

Treatment of Respiratory Syncytial Virus Infection: Past, Present and Future
by: Roymans, Dirk, et al.
Published: (2011)

Prophylaxis of respiratory syncytial virus infection: current status and prospects for vaccine development
by: A. S. Korovkin, et al.
Published: (2024-10-01)

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Variability of Respiratory Syncytial Virus Seasonality and Mortality
by: Light, Michael J.
Published: (2012)

Epidemiology and Diagnosis of Human Respiratory Syncytial Virus Infections
by: Akhter, Javed, et al.
Published: (2011)

Anti-Respiratory Syncytial Virus Agents from Phytomedicine
by: Odimegwu, Damian Chukwu, et al.
Published: (2011)

RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN: NEW RESEARCH
by: T.V. Kulichenko
Published: (2009-12-01)

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
by: Maxime Taquet, et al.
Published: (2025-06-01)

Factors Influencing Parental Decisions on Respiratory Syncytial Virus Immunoprophylaxis
by: Katherine E. Shedlock, MD, et al.
Published: (2025-09-01)

Highly Effective mRNA-LNP Vaccine Against Respiratory Syncytial Virus (RSV) in Multiple Models
by: Huarong Bai, et al.
Published: (2025-06-01)

A new drug for the prevention of diseases caused by respiratory syncytial virus
by: article Editorial
Published: (2023-01-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus
by: Mostafa Zayed, et al.
Published: (2025-12-01)

BRONCHOPULMONARY DYSPLASIA IS A RISK FACTOR IN THE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN
by: D.Yu. Ovsyannikov
Published: (2009-08-01)

The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
by: V. V. Vysochinskayа, et al.
Published: (2014-09-01)

Potential antiviral effects of the marine probiotic Paraliobacillus zengyii on the respiratory syncytial virus
by: Qianjin Fan, et al.
Published: (2025-06-01)

Post-licensure safety of respiratory syncytial virus vaccines, Vaccine Adverse Event Reporting System, United States, May 2023–December 2024
by: Junchao Li, et al.
Published: (2025-08-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION OF LOWER RESPIRATORY TRACT IN HOSPITALIZED CHILDREN UNDER 1 YEAR OF LIFE
by: A. V. Bogdanova, et al.
Published: (2018-04-01)

Structural and Functional Aspects of the Small Hydrophobic (SH) Protein in the Human Respiratory Syncytial Virus
by: Gan, Siok Wan, et al.
Published: (2011)

Research hotspots and global trends in respiratory syncytial virus over past five years
by: Xiaoli Tao, et al.
Published: (2025-08-01)

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN THE FIRST YEAR OF LIFE
by: I. V. Babachenko, et al.
Published: (2018-10-01)

Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece
by: George Gourzoulidis, et al.
Published: (2025-07-01)

Real time-PCR, ELISA, as an identification methods for Detection respiratory syncytial virus in children
by: Suad H. AL-Bashar, et al.
Published: (2023-01-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
by: Qin-Rui Lai, et al.
Published: (2025-06-01)

Cost-effectiveness of immunization strategies to protect infants against respiratory syncytial virus in the Netherlands
by: Annefleur C. Langedijk, et al.
Published: (2025-12-01)

Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner
by: Bosco A. Paes, et al.
Published: (2025-12-01)

Respiratory Syncytial Virus Induces B Cell Activating Factor (BAFF) in Airway Epithelium: A Potential Avenue for Mucosal Vaccine Development
by: Wael Alturaiki, et al.
Published: (2025-07-01)

Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus
by: Jordi Camps, et al.
Published: (2025-07-01)

Serological Diagnosis of Respiratory Syncytial Virus by ELISA Technique among Children with Respiratory Tract Infections in Beiji City, Iraq
by: Elaph M. Shuwaikh, et al.
Published: (2023-02-01)

Opposite Responses of Interferon and Proinflammatory Cytokines Induced by Human Metapneumovirus and Respiratory Syncytial Virus in Macrophages
by: Iván Martínez-Espinoza, et al.
Published: (2025-07-01)

Characteristics of respiratory syncytial virus infection in children in Pudong New Area， Shanghai， 2013‒2023
by: YU Qiumiao, et al.
Published: (2025-05-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
by: Qianqian Wang, et al.
Published: (2025-07-01)

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.
by: Andrew Young, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan
by: Akiko Mizukami, et al.
Published: (2024-12-01)

Ethnopharmacological survey of Rwandese medicinal plants used for respiratory infections. Effect of Senecio maranguensis extract against respiratory syncytial virus
by: Colores Uwamariya, et al.
Published: (2025-08-01)

Vaccines and Animal Models of Nipah Virus: Current Situation and Future Prospects
by: Chaoxiang Lv, et al.
Published: (2025-06-01)

Asymptomatic Bradycardia in a Neonate: A Rare Manifestation of Respiratory Syncytial Virus Infection with Literature Review
by: Abdulghani DW, et al.
Published: (2025-06-01)